AN EX-VIVO COMBINATION DRUG SENSITIVITY PLATFORM FOR PREDICTING SENSITIVITY TO FLT3 INHIBITOR-BASED COMBINATION IN ACUTE MYELOID LEUKEMIA

被引：0
|
作者：
Sahib, Noor Rashidha Bte Meera
Ying, Jen Wei
Ooi, Melissa
Chee, Yen Lin
Jayalakshmi
Mohamed, Jameelah Bte Sheik
Rashid, Masturah
Chow, Edward K. H.
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 08期
关键词：
D O I：
10.1158/1538-7445.FCS2023-P09
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P09
引用
收藏
页数：2
相关论文
共 50 条
  • [21] FLT3 Inhibitors in Combination with FLAG-IDA in Relapsed or Refractory Acute Myeloid Leukemia
    Bouligny, Ian
    Murray, Graeme
    Thuy Ho
    Gor, Juhi
    Zacholski, Kyle
    Wages, Nolan
    Grant, Steven
    Maher, Keri
    [J]. BLOOD, 2023, 142
  • [22] Gilteritinib-Based Combination Therapy in Adult Relapsed/Refractory FLT3 Mutated Acute Myeloid Leukemia
    Chen, Nianci
    Pan, Jiajia
    Zhou, Yile
    Mao, Liping
    Lou, Yinjun
    Qian, Jiejing
    Xu, Gaixiang
    Wei, Juying
    Zhou, De
    Shou, Lihong
    Li, Huang
    Yan, Minchao
    Zeng, Hui
    Fan, Cuihua
    Wu, Gongqiang
    Feng, Weiying
    Tong, Hongyan
    Jin, Jie
    Wang, Huafeng
    [J]. BLOOD, 2023, 142
  • [23] Iadademstat in combination with gilteritinib for patients with mutated FLT3 relapsed/refractory acute myeloid leukemia
    Fathi, Amir Tahmasb
    Arevalo, Mabel
    Gutierrez, Sonia
    Molero, Antonieta
    Sacilotto, Natalia
    Limon, Ana E.
    Faller, Douglas V.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [24] Enhancing Therapeutic Efficacy of FLT3 Inhibitors with Combination Therapy for Treatment of Acute Myeloid Leukemia
    Leifheit, Malia E.
    Johnson, Gunnar
    Kuzel, Timothy M.
    Schneider, Jeffrey R.
    Barker, Edward
    Yun, Hyun D.
    Ustun, Celalettin
    Goldufsky, Josef W.
    Gupta, Kajal
    Marzo, Amanda L.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (17)
  • [25] The Combination of Lanraplenib, a Selective SYK Inhibitor, and Gilteritinib, a FLT3 Inhibitor, Targets Aberrant Proliferation and Differentiation Blockade in Acute Myeloid Leukemia
    Carvajal, Luis A.
    McKeown, Michael R.
    Hood, Tressa
    Guo, Linlin
    Lin, Charles Y.
    DiMartino, Jorge F.
    [J]. BLOOD, 2023, 142
  • [26] Ningetinib, a novel FLT3 inhibitor, overcomes secondary drug resistance in acute myeloid leukemia
    Hu, Chuhong
    Zhang, Yvyin
    Yang, Jie
    Xu, Yanli
    Deng, Tingfen
    Li, Yumiao
    Xu, Shilin
    Wang, Shunqing
    Wang, Peihong
    [J]. CELL COMMUNICATION AND SIGNALING, 2024, 22 (01)
  • [27] Ex vivo Drug Sensitivity Imaging-based Platform for Primary Acute Lymphoblastic Leukemia Cells
    Rowland, Lauren
    Smart, Brandon
    Brown, Anthony
    Dettorre, Gino M.
    Gocho, Yoshihiro
    Hunt, Jeremy
    Yang, Wenjian
    Yoshimura, Satoshi
    Reyes, Noemi
    Du, Guoqing
    John, August
    Maxwell, Dylan
    Stock, Wendy
    Kornblau, Steven
    Relling, Mary, V
    Inaba, Hiroto
    Pui, Ching -Hon
    Bourquin, Jean-Pierre
    Karol, Seth E.
    Mullighan, Charles G.
    Evans, William E.
    Yang, Jun J.
    Crews, Kristine R.
    [J]. BIO-PROTOCOL, 2023, 13 (15):
  • [28] GNF-7, a novel FLT3 inhibitor, overcomes drug resistance for the treatment of FLT3‑ITD acute myeloid leukemia
    Xinhua Xiao
    Peihong Wang
    Weina Zhang
    Jiayi Wang
    Mansi Cai
    Hua Jiang
    Yingli Wu
    Huizhuang Shan
    [J]. Cancer Cell International, 23
  • [29] Correction to: Gilteritinib: a novel FLT3 inhibitor for acute myeloid leukemia
    Juanjuan Zhao
    Yongping Song
    Delong Liu
    [J]. Biomarker Research, 7
  • [30] Ex-vivo drug testing predicts chemosensitivity in acute myeloid leukemia
    Li, Lihui
    Tong, Yin
    Straube, Jasmin
    Zhao, Jinyan
    Gao, Yanting
    Bai, Ping
    Li, Jia
    Wang, Juan
    Wang, Hongling
    Wang, Xiaorui
    Huang, Sheng
    Xu, Wen
    Song, Xianmin
    Li, Li
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 2020, 107 (05) : 859 - 870
12345